Approvals/CIMA-AEMPS/AZELASTINA/FLUTICASONA TEVA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

AZELASTINA/FLUTICASONA TEVA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 369787e7b0f96bcb
Drug Cima Aemps Name: AZELASTINA/FLUTICASONA TEVA 137 MICROGRAMOS/50 MICROGRAMOS/APLICACION SUSPENSION PARA PULVERIZACION NASAL
Register Number: 89443
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2024-03-13
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 137 microgramos/50 microgramos/actuation
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

AZELASTINA HIDROCLORURO

0,989 mg/g

FLUTICASONA PROPIONATO

0,361 mg/g

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 13, 2024

Approval ID

369787e7b0f96bcb

Type

Standard